Report Code : CVMI10420251 | Published Date : April 10, 2025
nan
Reasons To Buy
nan
Scope
nan
Key Players
- Novartis AG
- Gilead Sciences Inc. (Kite Pharma)
- Bristol-Myers Squibb
- Amgen Inc.
- Biogen Inc.
- Astellas Pharma Inc.
- Organogenesis Holdings Inc.
- Integra LifeSciences Corporation
- Medtronic plc
- Smith & Nephew plc
- Thermo Fisher Scientific Inc.
- Vericel Corporation
- Bluebird Bio Inc.
- Sarepta Therapeutics Inc.
- Takeda Pharmaceutical Company Limited.
Global Regenerative Medicine Market Report
-
1. Global Regenerative Medicine Market Research Report
-
1.1 Study Objectives
1.2 Global Regenerative Medicine Market - Overview
1.3 Reason to Read This Report
1.4 Methodology and Forecast Analysis
-
2. Global Regenerative Medicine Market Research Report - Preface
-
2.1 Global Regenerative Medicine Market Research Report – Detailed Scope and Definitions
-
2.1.1 By Product
2.1.2 By Application
2.1.3 By End User
2.1.4 By Region
-
3. Global Regenerative Medicine Market Dynamics
-
3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
3.2. Restraints – By Product, By Application, By End User, By Country
3.3. Opportunities – By Product, By Application, By End User, By Country
3.4. Trends – By Product, By Application, By End User, By Country
3.5. PEST Analysis
3.6. Porters Five Rule Analysis
3.7. Company’s Share Analysis (CSA) by Region or By Country
3.8. Global Regenerative Medicine Market Research Report – DROTs Impact Analysis
-
4. Global Regenerative Medicine Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
-
4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
5. Global Regenerative Medicine Market, By Product, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
-
5.1 Cell Therapy
5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.2 Gene Therapy 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.3 Tissue Engineering 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.4 Platelet-Rich Plasma (PRP) 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.5 Biomaterials 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.6 Cord Blood Therapy 5.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
6.1 Orthopedics & Musculoskeletal Disorders
6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.2 Wound Care 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.3 Oncology 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.4 Cardiovascular Disorders 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.5 Dermatology 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.6 Neurology 6.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.7 Ophthalmology 6.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.8 Diabetes 6.8.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.8.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.8.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.8.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.9 Other Applications 6.9.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.9.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.9.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.9.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
7.1 Hospitals
7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7.2 Clinics 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7.3 Ambulatory Surgical Centers 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7.4 Academic & Research Institutes 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7.5 Specialty Centers 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7.6 Other End Users 7.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
8. Global Regenerative Medicine Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
-
8.1 North America
-
8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
9. North America Global Regenerative Medicine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
-
9.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
9.1.1 Cell Therapy
9.1.2 Gene Therapy
9.1.3 Tissue Engineering
9.1.4 Platelet-Rich Plasma (PRP)
9.1.5 Biomaterials
9.1.6 Cord Blood Therapy
-
9.2.1 Orthopedics & Musculoskeletal Disorders
9.2.2 Wound Care
9.2.3 Oncology
9.2.4 Cardiovascular Disorders
9.2.5 Dermatology
9.2.6 Neurology
9.2.7 Ophthalmology
9.2.8 Diabetes
9.2.9 Other Applications
-
9.3.1 Hospitals
9.3.2 Clinics
9.3.3 Ambulatory Surgical Centers
9.3.4 Academic & Research Institutes
9.3.5 Specialty Centers
9.3.6 Other End Users
-
9.4.1 United States
9.4.2 Canada
9.6 Regional Trends Analysis
9.7 North America Global Regenerative Medicine Market Research Report - Company Profiles
-
9.7.1 Company 1 (United States)
9.7.2 Company 2 (Canada)
9.7.3 Company 3 (Canada)
-
10.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
10.1.1 Cell Therapy
10.1.2 Gene Therapy
10.1.3 Tissue Engineering
10.1.4 Platelet-Rich Plasma (PRP)
10.1.5 Biomaterials
10.1.6 Cord Blood Therapy
-
10.2.1 Orthopedics & Musculoskeletal Disorders
10.2.2 Wound Care
10.2.3 Oncology
10.2.4 Cardiovascular Disorders
10.2.5 Dermatology
10.2.6 Neurology
10.2.7 Ophthalmology
10.2.8 Diabetes
10.2.9 Other Applications
-
10.3.1 Hospitals
10.3.2 Clinics
10.3.3 Ambulatory Surgical Centers
10.3.4 Academic & Research Institutes
10.3.5 Specialty Centers
10.3.6 Other End Users
-
10.4.1 Germany
10.4.2 United Kingdom
10.4.3 France
10.4.4 Spain
10.4.5 Italy
10.4.6 Russia
10.4.7 Netherlands
10.4.8 Poland
10.4.9 Rest of Europe
10.6 Regional Trends Analysis
10.7 Europe Global Regenerative Medicine Market Research Report - Company Profiles
-
10.7.1 Company 1 (Germany)
10.7.2 Company 2 (United Kingdom)
10.7.3 Company 3 (United Kingdom)
-
11.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
11.1.1 Cell Therapy
11.1.2 Gene Therapy
11.1.3 Tissue Engineering
11.1.4 Platelet-Rich Plasma (PRP)
11.1.5 Biomaterials
11.1.6 Cord Blood Therapy
-
11.2.1 Orthopedics & Musculoskeletal Disorders
11.2.2 Wound Care
11.2.3 Oncology
11.2.4 Cardiovascular Disorders
11.2.5 Dermatology
11.2.6 Neurology
11.2.7 Ophthalmology
11.2.8 Diabetes
11.2.9 Other Applications
-
11.3.1 Hospitals
11.3.2 Clinics
11.3.3 Ambulatory Surgical Centers
11.3.4 Academic & Research Institutes
11.3.5 Specialty Centers
11.3.6 Other End Users
-
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Australia & NZ
11.4.6 ASEAN
11.4.7 Rest of Asia-Pacific
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Regenerative Medicine Market Research Report - Company Profiles
-
11.7.1 Company 1 (China)
11.7.2 Company 2 (Japan)
11.7.3 Company 3 (Japan)
-
12.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
12.1.1 Cell Therapy
12.1.2 Gene Therapy
12.1.3 Tissue Engineering
12.1.4 Platelet-Rich Plasma (PRP)
12.1.5 Biomaterials
12.1.6 Cord Blood Therapy
-
12.2.1 Orthopedics & Musculoskeletal Disorders
12.2.2 Wound Care
12.2.3 Oncology
12.2.4 Cardiovascular Disorders
12.2.5 Dermatology
12.2.6 Neurology
12.2.7 Ophthalmology
12.2.8 Diabetes
12.2.9 Other Applications
-
12.3.1 Hospitals
12.3.2 Clinics
12.3.3 Ambulatory Surgical Centers
12.3.4 Academic & Research Institutes
12.3.5 Specialty Centers
12.3.6 Other End Users
-
12.4.1 Brazil
12.4.2 Mexico
12.4.3 Argentina
12.4.4 Peru
12.4.5 Colombia
12.4.6 Rest of Latin America
12.6 Regional Trends Analysis
12.7 Latin America Global Regenerative Medicine Market Research Report - Company Profiles
-
12.7.1 Company 1 (Brazil)
12.7.2 Company 2 (Mexico)
12.7.3 Company 3 (Mexico)
-
13.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
13.1.1 Cell Therapy
13.1.2 Gene Therapy
13.1.3 Tissue Engineering
13.1.4 Platelet-Rich Plasma (PRP)
13.1.5 Biomaterials
13.1.6 Cord Blood Therapy
-
13.2.1 Orthopedics & Musculoskeletal Disorders
13.2.2 Wound Care
13.2.3 Oncology
13.2.4 Cardiovascular Disorders
13.2.5 Dermatology
13.2.6 Neurology
13.2.7 Ophthalmology
13.2.8 Diabetes
13.2.9 Other Applications
-
13.3.1 Hospitals
13.3.2 Clinics
13.3.3 Ambulatory Surgical Centers
13.3.4 Academic & Research Institutes
13.3.5 Specialty Centers
13.3.6 Other End Users
-
13.4.1 Saudi Arabia
13.4.2 UAE
13.4.3 South Africa
13.4.4 Egypt
13.4.5 Israel
13.4.6 Rest of Middle East and Africa
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Regenerative Medicine Market Research Report - Company Profiles
-
13.7.1 Company 1 (Saudi Arabia)
13.7.2 Company 2 (UAE)
13.7.3 Company 3 (UAE)
-
14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
-
14.2.1 Novartis AG
14.2.2 Gilead Sciences Inc. (Kite Pharma)
14.2.3 Bristol-Myers Squibb
14.2.4 Amgen Inc.
14.2.5 Biogen Inc.
14.2.6 Astellas Pharma Inc.
14.2.7 Organogenesis Holdings Inc.
14.2.8 Integra LifeSciences Corporation
14.2.9 Medtronic plc
14.2.10 Smith & Nephew plc
14.2.11 Thermo Fisher Scientific Inc.
14.2.12 Vericel Corporation
14.2.13 Bluebird Bio Inc.
14.2.14 Sarepta Therapeutics Inc.
14.2.15 Takeda Pharmaceutical Company Limited.
-
15. Data Collection Method and Research Approach
-
16. Principal Presumptions and Acronyms